Investing
Bristol-Myers, Staples Fall Into Monday's 52-Week Low Club
Published:
Last Updated:
October 7, 2016: Here are four stocks trading with relatively heavy volume among 26 equities making new 52-week lows in Monday’s session. On the NYSE, advancers led decliners by about 2.5 to 1 and on the Nasdaq advancers led decliners by nearly the same margin.
Bristol-Myers Squibb Co. (NYSE: BMY) dropped more than 10% on Monday to post a new 52-week low of $74.93 against a 52-week high of $111.11. Volume of about 56 million was more than 4 times the daily average of around 12.1 million. The stock closed at $55.43 on Friday night. The company’s stock is tumbling following a failed clinical trial of its lung cancer treatment.
Staples Inc. (NASDAQ: SPLS) lost about 0.5% Monday to post a new 52-week low of $7.99 after closing Friday at $8.03. The 52-week high is $13.50. Volume of around 7 million was about 15% above the daily average of around 6 million shares traded. The company had no specific news Monday.
Novo Nordisk A/S (NYSE: NVO) dropped about 1.5% on Monday to post a new 52-week low of $40.11 after closing at $40.73 on Friday. The stock’s 52-week high is $59.00. Volume was about 60% higher than the daily average of around 2.8 million shares. The company had no specific news.
Fang Holdings Ltd. (NYSE: SFUN) lost about 3.5% Monday to post a new 52-week low of $3.87 after closing Friday at $4.01. The 52-week high is $8.17. Volume of around 3.5 million was slightly below the daily average of around 3.6 million shares traded. The utility company had no specific news. The Beijing-based online real-estate platform had no specific news Monday.
Are you ready for retirement? Planning for retirement can be overwhelming, that’s why it could be a good idea to speak to a fiduciary financial advisor about your goals today.
Start by taking this retirement quiz right here from SmartAsset that will match you with up to 3 financial advisors that serve your area and beyond in 5 minutes. Smart Asset is now matching over 50,000 people a month.
Click here now to get started.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.